Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app improve life for dialysis patients?

NCT ID NCT07291154

Recruiting now Disease control Sponsor: Yunfeng Xia Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial tests whether a smartphone app (Yueya mini-program and WeChat) can help people with end-stage renal disease who are on maintenance hemodialysis. The app provides personalized guidance on diet, exercise, medications, and health monitoring. Researchers will compare outcomes like quality of life, hospitalizations, and death rates between app users and those receiving standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Smartphone app (Yueya mini-program and WeChat) for personalized health guidance
What this could lead to
If it works, this could point toward a simple, low-cost way to help dialysis patients manage their health better and improve their quality of life.
What could go wrong
This is a relatively small, early-stage trial testing a behavioral intervention, not a drug. The app may not lead to meaningful improvements, and results may not apply to all dialysis patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE (ESRD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END STAGE RENAL DISEASE (ESRD) MAINTENANCE HEMODIALYSIS

Contacts and locations

Locations

  • The First Affiliated Hospital of Chongqing Medical University

    RECRUITING

    Chongqing, Chongqing Municipality, 400016, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.